127 related articles for article (PubMed ID: 536202)
21. [The study of safety control for the professional personals in the large dose treatment of Na 131I. On the estimation of the remaining dose following the internal administration (author's transl)].
Yamamoto C; Tanaka Y; Sasaki T; Kaneko M
Radioisotopes; 1977 Jun; 26(6):389-92. PubMed ID: 578956
[No Abstract] [Full Text] [Related]
22. Environmental radioactivity studies and regulatory issues.
Abalkina IL; Sarkisov AA; Linge II; Kazakov SV; Panchenko SV; Savelieva EA
Appl Radiat Isot; 2008 Nov; 66(11):1554-7. PubMed ID: 18602832
[TBL] [Abstract][Full Text] [Related]
23. State of the art of standard methods used for environmental radioactivity monitoring.
Engelbrecht R; Schwaiger M
Appl Radiat Isot; 2008 Nov; 66(11):1604-10. PubMed ID: 18515119
[TBL] [Abstract][Full Text] [Related]
24. Monitoring of airborne contamination during the handling of technetium-99m and radioiodine.
Eadie AS; Horton PW; Hilditch TE
Phys Med Biol; 1980 Nov; 25(6):1079-87. PubMed ID: 7208620
[TBL] [Abstract][Full Text] [Related]
25. Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
Lassmann M; Hänscheid H; Reiners C; Thomas SR
J Nucl Med; 2005 May; 46(5):900-1; author reply 901. PubMed ID: 15872369
[No Abstract] [Full Text] [Related]
26. Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapy.
Murcutt G; Edwards J; Boakye J; Davenport A
Kidney Int; 2008 Jun; 73(11):1316-9. PubMed ID: 18354377
[TBL] [Abstract][Full Text] [Related]
27. [Measurement of 131I concentration in saliva of a patient and monitoring of exposure and contamination in a ward (author's transl)].
Maekoshi H; Orito T; Nishizawa K; Ohara K; Watanabe T; Ohshima M
Radioisotopes; 1979 Mar; 28(3):180-3. PubMed ID: 554180
[No Abstract] [Full Text] [Related]
28. Radioactivity of blood samples taken from thyroidectomized thyroid carcinoma patients after therapy with (131)I.
Larkin A; Millan E; Noz M; Wagner S; Friedman K; Blum M
Thyroid; 2011 Sep; 21(9):1009-12. PubMed ID: 21834682
[TBL] [Abstract][Full Text] [Related]
29. "Hot shoes" from radioactive iodine treatment.
Bhargava P; George S
Thyroid; 2010 Aug; 20(8):931-2. PubMed ID: 20615133
[No Abstract] [Full Text] [Related]
30. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
31. Radiation doses to cohabitants of patients undergoing radioiodine ablation for thyroid cancer: poor compliance with radiation protection guidelines but low radiation exposure.
Gabriel S; Farman-Ara B; Bourrelly M; Carpentier O; Sebag F; Palazzo FF; De Micco C; Mancini J; Henry JF; Mundler O; Taïeb D
Nucl Med Commun; 2011 Sep; 32(9):829-33. PubMed ID: 21633315
[TBL] [Abstract][Full Text] [Related]
32. Environmental radiological surveillance in perspective: the relative importance of environmental media as a function of effluent pathway and radionuclides.
Denham DH
Health Phys; 1979 Mar; 36(3):273-81. PubMed ID: 226498
[No Abstract] [Full Text] [Related]
33. A retrospective study on the transition of radiation dose rate and iodine distribution in patients with I-131-treated well-differentiated thyroid cancer to improve bed control shorten isolation periods.
Yama N; Sakata K; Hyodoh H; Tamakawa M; Hareyama M
Ann Nucl Med; 2012 Jun; 26(5):390-6. PubMed ID: 22382609
[TBL] [Abstract][Full Text] [Related]
34. Choice and criteria for selection of sampling strategies in environmental radioactivity monitoring.
Scott EM; Dixon P; Voigt G; Whicker W
Appl Radiat Isot; 2008 Nov; 66(11):1575-81. PubMed ID: 18511288
[TBL] [Abstract][Full Text] [Related]
35. [Environmental radiation dose monitor after 125I radioactive seed implantation].
Zhuo SQ; Chen L; Zhang FJ; Zhao M; Zhang L; Liu J; Li K; Wu PH; Zheng QS; Wang Y
Ai Zheng; 2007 Jun; 26(6):666-8. PubMed ID: 17562278
[TBL] [Abstract][Full Text] [Related]
36. Thyroid remnant ablation with 1110MBq of 131I in outpatients: measurement of effective dose to household members and establishment of safety precautions.
Yoshimura M; Tsutsui H; Ikeda N; Koizumi K
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):101-8. PubMed ID: 23474638
[TBL] [Abstract][Full Text] [Related]
37. Iodide mumps: a case report of complicated radioactive iodine causing sialadenitis.
Lei L; Velasco O; Nobay F
Am J Emerg Med; 2012 Mar; 30(3):512.e5-6. PubMed ID: 21354757
[TBL] [Abstract][Full Text] [Related]
38. Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy.
Marriott CJ; Webber CE; Gulenchyn KY
Radiat Prot Dosimetry; 2007; 123(1):62-7. PubMed ID: 16825250
[TBL] [Abstract][Full Text] [Related]
39. Thyroid cancer radioiodine therapy: health service performance and radiation safety.
Vogiatzi S; Liossis A; Lamprinakou M
Radiat Prot Dosimetry; 2015 Jul; 165(1-4):434-8. PubMed ID: 25809109
[TBL] [Abstract][Full Text] [Related]
40. Procedures for radioactive I-131.
Sharma SC
Med Dosim; 1988 Dec; 13(4):201-2. PubMed ID: 3252901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
